Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | PPARD | Q03181 | 1/20 | 0.63 |
| ▸ | PPARA | Q07869 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.58 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | AR | P10275 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | TNKS | O95271 | 1/20 | 0.56 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | CCR3 | P51677 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31005006 | 0.98 | ALDH1A1 (0.61) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| Fluoride SCHEMBL28006168 | 0.98 | ALDH1A1 (0.61) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL17655660 | 0.90 | TNKS (0.59) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL3141953 | 0.89 | ALDH1A1 (0.56) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL30185876 | 0.88 | ALDH1A1 (0.51) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL29582029 | 0.88 | ALDH1A1 (0.51) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL16934106 | 0.88 | ALDH1A1 (0.51) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL16933899 | 0.87 | ALDH1A1 (0.50) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL16933701 | 0.87 | ALDH1A1 (0.50) | ALDH1A1PPARGPPARDPPARACYP3A4 | |
| SCHEMBL11553231 | 0.86 | ALDH1A1 (0.53) | ALDH1A1PPARGPPARDPPARACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069551-A1 | Patch for treating demyelinating diseases | UNIV MAINZ JOHANNES GUTENBERG (DE) | 2026-03-12 | — | — | US | claimed |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4633638-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | Luminous Mind Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4587027-A1 | PATCH FOR TREATING DEMYELINATING DISEASES | Johannes Gutenberg-Universität Mainz (DE) | 2025-07-23 | — | — | EP | claimed |
| US-20250144164-A1 | COMPOSITIONS, METHODS, AND MEDICAL COMPOSITIONS FOR TREATMENT OF AND MAINTAINING THE HEALTH OF THE LIVER | UNIGEN, INC. (US) | 2025-05-08 | — | — | US | claimed |
| EP-4410937-A2 | HOUSEHOLD PRODUCT DELIVERING WARMING AND/OR TINGLING SENSATIONS | Takasago International Corporation (JP) | 2024-08-07 | — | — | EP | claimed |
| US-12018227-B2 | Encapsulated fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-06-25 | — | — | US | claimed |
| WO-2024130044-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | LUMINOUS MIND INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024107445-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES, INC. (US) | 2024-05-23 | — | — | WO | claimed |
| US-4053657-A | FOODS AND FLAVOR USE OF 1-(3,3-DIMETHYL-2-NORBORNYL-2-PROPANONE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-10-11 | — | — | US | claimed |
| US-4053655-A | Uses of α-oxy(oxo) sulfides and ethers in foodstuffs and flavors for foodstuffs | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-10-11 | — | — | US | claimed |
| US-4044164-A | BERRY, CEREAL, NUT, BROCCOLI, ONION, CITRUS, JASMIN, MILK CARAMEL, GRAPE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-08-23 | — | — | US | claimed |
| US-4000329-A | Flavoring compositions and foods containing one or more alkyl side chain methyl substituted or unsubstituted 2,2,6-trimethyl-1-cyclohexen-1-vinyl alkanoates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-12-28 | — | — | US | claimed |
| US-4000327-A | BERRY FRUIT FOODSTUFFS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-12-28 | — | — | US | claimed |
| US-3984579-A | Novel flavoring compositions and products containing isomer mixtures containing high proportions of 2-methyl-cis-3-pentenoic acid | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-10-05 | — | — | US | claimed |
| US-3978239-A | Foodstuff and flavoring containing C1 -C6 alkyl-2-methyl-3,4-pentadienoates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-08-31 | — | — | US | claimed |
| US-3976801-A | Flavoring compositions containing alkyl esters of 2-methyl-4-pentenoic acid | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-08-24 | — | — | US | claimed |
| US-3959508-A | Flavoring compositions containing mixture of 2,2,6-trimethyl-1-cyclohexen-1-ylacetaldehyde and 2,6,6-trimethyl-1-crotonyl-1,3-cyclohexadiene | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-05-25 | — | — | US | claimed |
| US-3940499-A | Food or flavor containing 2,6,6-trimethyl-1-cyclohexen-1-ylacetaldehyde | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069551-A1 | Patch for treating demyelinating diseases | PMP22, PLP2, MYT1 | ALDH1A1 4621/4885PPARG 772/4885PPARD 2456/4885 |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | PDE9A, PDE3A, PDE2A | ALDH1A1 1406/4885PPARG 2893/4885PPARD 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.